	The potential link between inflammatory bowel disease and male erectile dysfunction: mechanistic insights and novel therapeutic perspectives. Front Immunol Li S, Cao H, Liang Y, Lv C, Ma Y, Yang T, Yuan B, Wei W. PMID: 41562062 [PubMed - indexed for MEDLINE]
	The effects of steroid treatment on osteoporosis in patients with inflammatory bowel disease: A systematic review and meta-analysis. Medicine (Baltimore) Li CC, Xu LP, Zheng TT, Wu XL. PMID: 41560068 [PubMed - indexed for MEDLINE]
	Usefulness of Therapeutic Drug Monitoring of Vedolizumab in the Control of Response in Crohn's Disease. Med Clin (Barc) Moñino-Dominguez L, Aguado-Paredes A, Cordero-Ramos J, Tirado-Pérez MJ, Martínez-Escudero A, Argüelles-Arias F, Merino-Bohórquez V. PMID: 41558253 [PubMed - as supplied by publisher]
	Endoscopic and pathologic findings of esophagogastroduodenal involvement in Crohn disease in Korea: a prospective single-center cohort study. Inflamm Bowel Dis Kim GH, Kim J, Ahn JY, Park SH, Hwang SW, Ye BD, Jung HY, Yang SK. PMID: 41556938 [PubMed - as supplied by publisher]
	A Cross-Tissue Transcriptome-Wide Association Study Reveals Novel Susceptibility Genes for Inflammatory Bowel Disease. FASEB J Zhou Y, Guo J. PMID: 41556068 [PubMed - indexed for MEDLINE]
	Associations between demographic, clinical and dietary factors and flares in inflammatory bowel disease: the PRognostic effect of Environmental factors in Crohn's and Colitis (PREdiCCt) prospective cohort study. Gut Constantine-Cooke N, Gros B, Plevris N, Williams LJ, Jones GR, Kyle J, Kennedy NA, Velasco-Pardo V, Rudge A, Alexander D, Anderson CA, Brusco de Freitas M, Derr LM, Derikx LA, Gilchrist S, Henderson P, Horgan GW, Irving P, Lamb CA, Jostins-Dean L, Lindsay JO, MacDonald J, Mowat C, Murray C, Parkes M, Siakavellas SI, Vallejos CA, Gaya DR, Rhodes JM, Johnstone AM, Weir CJ, Lees CW, PREdiCCt study group. PMID: 41554630 [PubMed - as supplied by publisher]
	Limited willingness to switch from intravenous to subcutaneous treatment in paediatric inflammatory bowel disease. BMJ Paediatr Open Eindor-Abarbanel A, Shalem T, Badalov O, Weiss B, Cohen DL, Shalev R, Yerushalmi B, Yerushalmy-Feler A, Topf Olivestone C, Shirin H, Broide E, Richter V. PMID: 41554606 [PubMed - indexed for MEDLINE]
	Comparative Efficacy and Safety of Advanced Therapies in Maintenance Treatment of AdultÂ Patients with Moderate-to-Severe Crohn's Disease: A Systematic Literature Review and Network Meta-Analysis. Adv Ther Schreiber S, Danese S, Colombel JF, Hisamatsu T, Irving PM, Park H, Kim DH, Lee YN, Hanauer SB. PMID: 41553714 [PubMed - as supplied by publisher]
	Prevalence of Cytomegalovirus in Patients With Newly Diagnosed, Flare-Up, and Acute Severe Ulcerative Colitis. Cureus Shrestha M, Shrestha R, Khanal A, Basnet B, Poudyal NS, Yadav AK, Paudel MS. PMID: 41552097 [PubMed]
	Association of FADS2 polymorphism rs174538 with fatty acid metabolism and disease severity in Japanese patients with Crohn's disease. World J Gastroenterol Matsuzawa H, Ito Z, Uchiyama K, Motoi Y, Ohtaki Y, Iwashita Y, Suzuki S, Nakada T, Koido S, Kojima K, Murohashi K, Saruta M, Ohkusa T, Kubota T. PMID: 41551830 [PubMed - indexed for MEDLINE]
	Reducing agents for induction and maintenance therapy achieve long-term remission of refractory ulcerative colitis: A case report and review of literature. World J Gastroenterol Sylvestre PB. PMID: 41551825 [PubMed - indexed for MEDLINE]
	Scutellaria baicalensis Georgi as a potential therapeutic drug intervention in ulcerative colitis: Mechanisms of action and clinical trials. World J Gastroenterol Ding Y, Wang CY, Pan YT, Wang YJ, Zhao AG, Wen HZ. PMID: 41551522 [PubMed - indexed for MEDLINE]
	Annexin A1 and A2 in inflammatory bowel disease pathogenesis: exploring new avenues for diagnosis and treatment. Front Immunol Murshed NMF, Shetty P, Jayaswamy PK, Jacob AM, Alawadhi SSA, Hosapatna Laxminarayana KP. PMID: 41550928 [PubMed - indexed for MEDLINE]
	Protective Effect of Flavonoids in Ulcerative Colitis: A Systematic Review and Meta-Analysis of Preclinical Studies. Phytother Res Tang J, Yuan L, Qu Z, Li C, Ran L, Wang P, Sun G, Hao Y, Zhang Y. PMID: 41549380 [PubMed - as supplied by publisher]
	Comments on "Week 2 remission with vedolizumab as a predictor of long-term remission in patients with ulcerative colitis: a multicenter, retrospective, observational study". Intest Res Pinton P. PMID: 41548898 [PubMed - as supplied by publisher]
	Biomolecular Fingerprint of Crohn's Disease: A Comparative Raman Spectroscopic Study of Blood and Tissue Samples. J Biophotonics Ghauri MD, Fernandez MV, Santacroce G, Chanda S, Zammarchi I, Capobianco I, Sekar SKV, Ghosh S, Komolibus K, Andersson-Engels S, Iacucci M, Gautam R. PMID: 41548573 [PubMed - indexed for MEDLINE]
	Diagnostic value of serum lipocalin-2 in Egyptian patients with inflammatory bowel disease: A case-control study. Egypt J Immunol Abd El Malak MWN, El Nakeeb NA, Abo Daif MA, Fathi MEA, Nassef MA, Guirguis RNM. PMID: 41546879 [PubMed - indexed for MEDLINE]
	Polygenic risk scores for Crohn's disease risk prediction in a Chinese population: insights from multi-ethnic genome-wide association studies. Eur J Med Res Guan L, Liu H, Zhao N, Sun H, Zhao L, Zhang J, Shu Q. PMID: 41545884 [PubMed - as supplied by publisher]
	Efficacy and safety of subcutaneous guselkumab induction therapy in participants with moderately to severely active ulcerative colitis (ASTRO): a double-blind, treat-through, randomised, placebo-controlled, phase 3 trial. Lancet Gastroenterol Hepatol Long M, Allegretti JR, Danese S, Germinaro M, Baker T, Alvarez Y, Kavalam M, Han C, Jörgens S, Jiang L, Zhang H, Hisamatsu T, Rubin DT, Peyrin-Biroulet L, ASTRO Study Group. PMID: 41544637 [PubMed - as supplied by publisher]
	Plasma Proteomics for Risk Prediction and Therapeutic Target Discovery in Crohn's Disease and Ulcerative Colitis. Inflamm Bowel Dis Gan X, Zhang Y, Zhang Y, Ye Z, Yang S, Xiang H, Huang Y, Wu Y, Zhang Y, Qin X. PMID: 41544041 [PubMed - as supplied by publisher]

Articles 1 - 20 / 56507

Page 1 of 2826



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy